Chen Yang Luke Sells Shares of 111, Inc. (YI)

Chen Yang Luke sold 1,440 shares of 111, Inc. for $388.80 on May 26.

Written by EarningsIQ · Published Jun 16, 2026, 7:00 AM EDT · Updated Jun 16, 2026, 3:00 PM EDT

Key Points

Chen Yang Luke sold 1,440 shares of 111, Inc. on May 26 for $388.80 at an average price of $0.27 per share.
111, Inc. trades on NasdaqGM under the ticker YI, with a market cap of about $40.2 million and a 52-week range of $2.48 to $11.17.
Other institutional investors like Renaissance Technologies LLC and Serenus Wealth Advisors, LLC have adjusted their positions in 111, Inc.

On May 26, 2026, Chen Yang Luke sold 1,440 shares of 111, Inc. (NasdaqGM: YI). The transaction was valued at $388.80, with shares sold at an average price of $0.27 each. This sale was not part of a pre-scheduled trading plan.

What Changed in Chen Yang Luke's 111, Inc. Position

Chen Yang Luke's recent sale of 1,440 shares of 111, Inc. represents a reduction in his holdings. The shares were sold at an average price of $0.27, totaling $388.80. This transaction was conducted without a predetermined plan.

Other Institutional Activity in 111, Inc.

Several institutional investors have also made moves in 111, Inc. Renaissance Technologies LLC increased its holdings by 300 shares, bringing its total to 13,014 shares worth about $84,851. On the other hand, Serenus Wealth Advisors, LLC reduced its stake by 64 shares, ending with 4,320 shares valued at approximately $321,334. Citigroup Inc entered the stock with 207 shares, while Morgan Stanley decreased its position by 27 shares, now holding 113 shares valued at $737. UBS Group AG significantly trimmed its holdings by 203 shares, leaving it with 100 shares worth $652.

111, Inc. Stock Snapshot

Shares of 111, Inc. (NasdaqGM: YI) are trading near $4.57. The company has a market capitalization of around $40.2 million and a forward P/E ratio of 32.64. Its stock has seen a 52-week low of $2.48 and a high of $11.17. The 50-day moving average is $5.88, while the 200-day moving average stands at $5.40. The company has a current ratio of 1.08 and a quick ratio of 0.37, with a debt-to-equity ratio of 150.93.

Recent Earnings

111, Inc. reported revenue of approximately $11.39 billion, although revenue growth was negative at -33.1%. The company is not currently profitable, with a net margin of -0.75% and a return on equity of -14.84%. The next earnings report is expected on March 19, 2026.

Insider Buying and Selling at 111, Inc.

Recent insider activity at 111, Inc. includes several sales. On June 15, 2026, Sun Jian David sold 58,800 shares and Chen Yang Luke sold 44,000 shares, both at an average price of $0.23 per share. Earlier, on June 12, Chen Yang Luke offloaded 49,920 shares, also at $0.23 per share. Sun Jian David made additional sales on June 11 and June 10, disposing of 111,100 and 115,440 shares, respectively.

About 111, Inc.

111, Inc. operates in the healthcare sector, focusing on medical distribution. The company, headquartered in Shanghai, China, runs an integrated online and offline platform, offering supply chain services, product promotion, and customer analytics. It serves a wide range of clients, including pharmacies and pharmaceutical companies, through its B2C and B2B segments. The company was founded in 2010 and is led by CEO Mr. Junling Liu.

Bottom Line

Chen Yang Luke's recent sale of shares in 111, Inc. highlights ongoing insider activity at the company. Investors often track such transactions for insights into insider sentiment. However, it's important to remember these trades reflect past actions and may not indicate current positions or future decisions.